Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000237085, described as "pseudogene similar to part of CDGSH iron sulfur domain 2," is classified as a **pseudogene**—a nonfunctional DNA segment that closely resembles a functional gene, in this case, CISD2 (CDGSH iron sulfur domain 2)[3][5][7]. Pseudogenes **do not encode functional proteins** and are generally considered "genomic fossils" or remnants of formerly productive genes lost through mutations like frameshifts or premature stop codons[4][2]. As such, this entry is **not a functional target**, receptor, or enzyme, and it is not employed directly in therapeutic targeting, disease association, or drug interaction contexts. Pseudogenes can sometimes be transcribed and, in rare cases, exert regulatory effects, but there is **no evidence of function or clinical relevance** for this specific pseudogene[6]. Any structured or functional roles attributed to CISD2 do not apply to this pseudogene, and a focus on the functional gene (CISD2) is necessary if therapeutic relevance is required.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of CDGSH iron sulfur domain 2.